Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000939767-18-000005
Filing Date
2018-01-19
Accepted
2018-01-19 20:21:01
Documents
2
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_151641124605599.html 5  
1 FORM 5 wf-form5_151641124605599.xml 5 4371
2 POA_JAN_2018_JEFF ex-24.htm EX-24 3684
  Complete submission text file 0000939767-18-000005.txt   9599
Mailing Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 210 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Hessekiel Jeffrey (Reporting) CIK: 0001599803 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-30235 | Film No.: 18538549